Variant report
Variant | esv2502603 |
---|---|
Chromosome Location | chr3:28167062-28168554 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:28159859..28162857-chr3:28168438..28170646,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187287538 | chr3:28167094-28167095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73822527 | chr3:28167112-28167113 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs568401271 | chr3:28167123-28167124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs370925699 | chr3:28167129-28167130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374692055 | chr3:28167195-28167196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554322672 | chr3:28167256-28167257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs190646454 | chr3:28167263-28167264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs111474119 | chr3:28167332-28167333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs557240730 | chr3:28167405-28167406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113630608 | chr3:28167430-28167431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs78610006 | chr3:28167468-28167469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs79780538 | chr3:28167492-28167493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545812911 | chr3:28167531-28167532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559614488 | chr3:28167548-28167549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572320208 | chr3:28167561-28167562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs550946926 | chr3:28167571-28167572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536456779 | chr3:28167603-28167604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549913188 | chr3:28167641-28167642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540112632 | chr3:28167685-28167686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368197406 | chr3:28167729-28167730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561183596 | chr3:28167730-28167731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570439783 | chr3:28167759-28167760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191694840 | chr3:28167772-28167773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549956243 | chr3:28167773-28167774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183115094 | chr3:28167774-28167775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539030864 | chr3:28167779-28167780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532585667 | chr3:28167802-28167803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115140509 | chr3:28167813-28167814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187652265 | chr3:28167847-28167848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71319035 | chr3:28167856-28167857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149688090 | chr3:28167858-28167859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs528035383 | chr3:28167885-28167886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548210379 | chr3:28167900-28167901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs113056141 | chr3:28167934-28167935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs71624702 | chr3:28167935-28167936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs398051733 | chr3:28167959-28167960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192642383 | chr3:28168029-28168030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188592056 | chr3:28168066-28168067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557177483 | chr3:28168133-28168134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs546700302 | chr3:28168156-28168157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570626028 | chr3:28168217-28168218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs112412074 | chr3:28168236-28168237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs150948565 | chr3:28168237-28168238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539640530 | chr3:28168243-28168244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs71626503 | chr3:28168252-28168253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185684356 | chr3:28168263-28168264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9814632 | chr3:28168361-28168362 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs145498986 | chr3:28168390-28168391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 16618734 | CNVD |
Cancer | 20164919 | CNVD |
Developmental delay | 21147756 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:28165600-28167400 | Enhancers | Primary B cells from peripheral blood | blood |
2 | chr3:28166400-28167200 | Enhancers | Dnd41 | blood |
3 | chr3:28166600-28167400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
4 | chr3:28167000-28167400 | Enhancers | Primary B cells from cord blood | blood |
5 | chr3:28167400-28168400 | Weak transcription | Primary B cells from cord blood | blood |